Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Adilson Joaquim Westheimer Cavalcante, MD, PhD
FDA Inspection
•Adilson Joaquim Westheimer Cavalcante, MD, PhD•December 12, 2025

Adilson Joaquim Westheimer Cavalcante, MD, PhD – FDA Inspection, Dec 12, 2025

Record Details

This FDA Inspection record concerns Adilson Joaquim Westheimer Cavalcante, MD, PhD, with an inspection on December 12, 2025, covering biologics.

Company
Adilson Joaquim Westheimer Cavalcante, MD, PhD
Inspection Date
December 12, 2025
Product Type
Biologics
Person
  • Tawny L. Colling (Company Rep)
View Company Profile

ID · 7f5ac25b-0fac-4724-bee1-da76c1412f03

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number
1296028
FDA center
Biologics
Project area
Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Adilson Joaquim Westheimer Cavalcante, MD, PhD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.